Literature DB >> 17334358

Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung.

Phil Oh1, Per Borgström, Halina Witkiewicz, Yan Li, Bengt J Borgström, Adrian Chrastina, Koji Iwata, Kurt R Zinn, Richard Baldwin, Jacqueline E Testa, Jan E Schnitzer.   

Abstract

How effectively and quickly endothelial caveolae can transcytose in vivo is unknown, yet critical for understanding their function and potential clinical utility. Here we use quantitative proteomics to identify aminopeptidase P (APP) concentrated in caveolae of lung endothelium. Electron microscopy confirms this and shows that APP antibody targets nanoparticles to caveolae. Dynamic intravital fluorescence microscopy reveals that targeted caveolae operate effectively as pumps, moving antibody within seconds from blood across endothelium into lung tissue, even against a concentration gradient. This active transcytosis requires normal caveolin-1 expression. Whole body gamma-scintigraphic imaging shows rapid, specific delivery into lung well beyond that achieved by standard vascular targeting. This caveolar trafficking in vivo may underscore a key physiological mechanism for selective transvascular exchange and may provide an enhanced delivery system for imaging agents, drugs, gene-therapy vectors and nanomedicines. 'In vivo proteomic imaging' as described here integrates organellar proteomics with multiple imaging techniques to identify an accessible target space that includes the transvascular pumping space of the caveola.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334358      PMCID: PMC1979160          DOI: 10.1038/nbt1292

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  47 in total

Review 1.  Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo.

Authors:  J E Schnitzer
Journal:  Adv Drug Deliv Rev       Date:  2001-07-28       Impact factor: 15.470

Review 2.  Pulmonary drug delivery systems: recent developments and prospects.

Authors:  H M Courrier; N Butz; Th F Vandamme
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2002       Impact factor: 4.889

3.  Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking.

Authors:  Peter Thomsen; Kirstine Roepstorff; Martin Stahlhut; Bo van Deurs
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

4.  Update on the cellular and molecular basis of capillary permeability.

Authors:  J E Schnitzer
Journal:  Trends Cardiovasc Med       Date:  1993 Jul-Aug       Impact factor: 6.677

Review 5.  Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors.

Authors:  E Galanis; R Vile; S J Russell
Journal:  Crit Rev Oncol Hematol       Date:  2001-06       Impact factor: 6.312

Review 6.  Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies.

Authors:  H F Dvorak; J A Nagy; A M Dvorak
Journal:  Cancer Cells       Date:  1991-03

7.  Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER.

Authors:  L Pelkmans; J Kartenbeck; A Helenius
Journal:  Nat Cell Biol       Date:  2001-05       Impact factor: 28.824

8.  Role of GTP hydrolysis in fission of caveolae directly from plasma membranes.

Authors:  J E Schnitzer; P Oh; D P McIntosh
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

9.  Specific albumin binding to microvascular endothelium in culture.

Authors:  J E Schnitzer; W W Carley; G E Palade
Journal:  Am J Physiol       Date:  1988-03

10.  Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases.

Authors:  J E Schnitzer; J Liu; P Oh
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

View more
  125 in total

Review 1.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

Review 2.  Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues.

Authors:  Noelle M Griffin; Jan E Schnitzer
Journal:  Mol Cell Proteomics       Date:  2010-06-14       Impact factor: 5.911

3.  The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium.

Authors:  Hua Zhang; Ning Li; Padmini Sirish; Lisa Mahakian; Elizabeth Ingham; Fitz-Roy Curry; Soichiro Yamada; Nipavan Chiamvimonvat; Katherine W Ferrara
Journal:  J Control Release       Date:  2012-07-07       Impact factor: 9.776

4.  Construction of metabolically biotinylated adenovirus with deleted fiber knob as targeting vector.

Authors:  Yanzheng Liu; Philippe Valadon; Jan E Schnitzer
Journal:  Virol J       Date:  2010-11-12       Impact factor: 4.099

Review 5.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

6.  Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration.

Authors:  Xiaowu Gu; Steven J Fliesler; You-Yang Zhao; William B Stallcup; Alex W Cohen; Michael H Elliott
Journal:  Am J Pathol       Date:  2013-12-08       Impact factor: 4.307

Review 7.  Nanotechnology: toxicologic pathology.

Authors:  Ann F Hubbs; Linda M Sargent; Dale W Porter; Tina M Sager; Bean T Chen; David G Frazer; Vincent Castranova; Krishnan Sriram; Timothy R Nurkiewicz; Steven H Reynolds; Lori A Battelli; Diane Schwegler-Berry; Walter McKinney; Kara L Fluharty; Robert R Mercer
Journal:  Toxicol Pathol       Date:  2013-02-06       Impact factor: 1.902

8.  Spatially controlled assembly of affinity ligand and enzyme cargo enables targeting ferritin nanocarriers to caveolae.

Authors:  Vladimir V Shuvaev; Makan Khoshnejad; Katherine W Pulsipher; Raisa Yu Kiseleva; Evguenia Arguiri; Jasmina C Cheung-Lau; Kathleen M LeFort; Melpo Christofidou-Solomidou; Radu V Stan; Ivan J Dmochowski; Vladimir R Muzykantov
Journal:  Biomaterials       Date:  2018-09-12       Impact factor: 12.479

Review 9.  Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis.

Authors:  Ayman El-Sayed; Hideyoshi Harashima
Journal:  Mol Ther       Date:  2013-04-16       Impact factor: 11.454

Review 10.  Targeted delivery of therapeutics to endothelium.

Authors:  Eric Simone; Bi-Sen Ding; Vladimir Muzykantov
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.